The pretreatment of fibroblasts from PCOS patients with serine kinase inhibitors enhanced the tyrosine autophosphorylation of the insulin receptor [69], suggesting that a currently non-identified entity with serine kinase activity is involved in the process [60]. The gene discussed is INSR; the disease is polycystic ovary syndrome.